Literature DB >> 24772318

Experimental study on Qizhu formula for modulating survivin, an inhibitor of apoptosis, in MGC-803 gastric cancer cells.

Hao Wen1, Xiaohua Wang1, Zhaowei Shan2.   

Abstract

The aim of this study was to investigate the mechanism of action of Qizhu formula, a Chinese medicinal empirical formula, in modulating the action of survivin, an inhibitor of apoptosis, in MGC-803 gastric cancer cells. Western blot analysis and reverse transcription-polymerase chain reaction (RT-PCR) were applied to detect the effect of varying concentrations of Qizhu formula in the modulation of the expression of survivin in MGC-803 human gastric adenocarcinoma cells. The western blot analysis results demonstrated that Qizhu formula exerted no significant effects on the protein expression of the β-actin housekeeping gene, whereas it exerted a significant inhibitory effect on the protein expression of the apoptosis-related survivin gene at concentrations of 250 μg/ml and, particularly, 500 μg/ml. RT-PCR was used to detect the effect of Qizhu formula on survivin mRNA in MGC-803 human gastric adenocarcinoma cells. The ratio of survivin/β-actin in the 0.1% dimethylsulfoxide and the 125, 250 and 500 μg/ml groups of Qizhu formula was 0.4543, 0.4025, 0.2415 and 0.2235, respectively. Therefore, Qizhu formula exerted a distinct inhibitory effect on the mRNA expression of survivin in MGC-803 cells in a dose-dependent manner. In conclusion, Qizhu formula may modulate the apoptosis of MGC-803 human gastric adenocarcinoma cells, which is associated with the downregulation of survivin mRNA and protein expression.

Entities:  

Keywords:  MGC-803 gastric cancer cells; Qizhu formula; survivin

Year:  2014        PMID: 24772318      PMCID: PMC3999120          DOI: 10.3892/mco.2014.268

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  6 in total

1.  A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma.

Authors:  G Ambrosini; C Adida; D C Altieri
Journal:  Nat Med       Date:  1997-08       Impact factor: 53.440

2.  Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma.

Authors:  Evzen Krepela; Petra Dankova; Erika Moravcikova; Anna Krepelova; Jan Prochazka; Jan Cermak; Jan Schützner; Petr Zatloukal; Kamila Benkova
Journal:  Int J Oncol       Date:  2009-12       Impact factor: 5.650

3.  Preoperative survivin mRNA detection in peripheral blood is an independent predictor of outcome in esophageal carcinoma.

Authors:  Andreas-Claudius Hoffmann; Daniel Vallböhmer; Peter Grimminger; Ralf Metzger; Klaus L Prenzel; Arnulf H Hoelscher; Jan Brabender
Journal:  Pharmacogenomics       Date:  2010-03       Impact factor: 2.533

4.  Prognostic significance and different properties of survivin splicing variants in gastric cancer.

Authors:  Hua Meng; Caide Lu; Hideaki Mabuchi; Nobuhiko Tanigawa
Journal:  Cancer Lett       Date:  2004-12-28       Impact factor: 8.679

5.  DcR3 and survivin are highly expressed in colorectal carcinoma and closely correlated to its clinicopathologic parameters.

Authors:  Qi-lian Liang; Bi-rong Wang; Guo-hong Li
Journal:  J Zhejiang Univ Sci B       Date:  2009-09       Impact factor: 3.066

6.  [Expression of survivin in human gastric adenocarcinomas: correlation with proliferation and apoptosis].

Authors:  Xue-quan Yao; Fu-kun Liu; Xiao-ping Qi; Bo Wu; Hong-lin Yin; Heng-hui Ma; Qun-li Shi; Xiao-jun Zhou; Jie-shou Li
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2004-02-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.